CONTACT  

Quotes and Advance Reviews

“Longevity is the most complex, important, and impactful field, and the biggest business opportunity of this century! The problem is that there is so much information about longevity that even beginning a quest for answers can be overwhelming. Thankfully Margaretta Colangelo and Dmitry Kaminskiy, the ideal people to distill this information to its essence, have done so in their new book "Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History”. Colangelo and Kaminskiy are experts and thought leaders in this massive field. They have conducted extensive research and formed partnerships with commercial, academic, and nonprofits. They understand that the time is now to open the gates and help everyone understand the importance and the possibilities that await us all to have longer, healthier, and higher-quality lives.”

          

- Andrew Bogle, Managing Director, Reva Capital Markets (US)

“The new book “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Dmitry Kaminskiy and Margaretta Colangelo is a highly topical, comprehensive and insightful explanation of the potential opportunities and threats of longevity research and how the convergence of AI, advanced data science, and longevity research will accelerate important medical breakthroughs that will benefit us all. By sharing their in-depth understanding of this burgeoning industry, including the different roles of the multiple stakeholders, the authors have enabled all of us to gain a better understanding and consider how we might contribute to this exciting field of research.”

          

- Karen Taylor, Research Director, Deloitte Centre for Health Solutions, UK

“We can all be grateful to Dmitry Kaminskiy and Margaretta Colangelo for producing this book. The depth of research involved is clear and the content will be of interest to many people whether they are medical researchers, policy-makers, healthcare providers, insurers, investors etc. The authors have captured the enormity of this emerging industry and its likely positive impact on human (and animal) health and happiness. It’s very striking to read “The Longevity industry will be the biggest and most complex industry of all time”. My initial reaction was well everyone says something similar about their area of interest. Then on reflection, I had to agree! It makes sense that it will be larger than the current pharmaceutical market. After all, we will all age, 8-10 billion of us, and we will all be interested in slowing that aging, and especially interested in maintaining our health-span as long as possible. Our knowledge of human biochemistry has now advanced to a point where we can identify interventions for aging. Many scientists are themselves experimenting by taking drugs and supplements they believe will help slow their personal aging, while also adjusting lifestyle factors such as diet, exercise, sleep, mind-state and even intermittent fasting. Experiments on flies, worms and mice have shown quite dramatic extension of both healthspan and lifespan with similar interventions. Extending the number of years that humans live in good health does appear to be eminently possible, with the weakest link possibly being our own self-discipline. But how wonderful to have a real choice. I truly believe that within the next few years the progress in understanding will give us that choice.”

          

- Dr. David Brown, PhD, Co-Founder, Healx, UK, Sponsor of the Global Sepsis Challenge, Former Global Head of Drug Discovery at Roche, Co-Inventor of Viagra

As we enter the Age of Longevity, it is clear that aging is becoming one of the biggest economic opportunities of the century. The field of longevity is growing exponentially, together with the most advanced technologies in early diagnostics and treatments for slowing down aging, extending healthy lifespans, and fighting killer monsters like cancer and heart disease “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Dmitry Kaminsky and Margaretta Colangelo analyzes the current trends, companies and initiatives united by one mission: helping people live longer and healthier lives

          

- Sergey Young, Founder & CEO, Longevity Vision Fund

““Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” is a compelling cris de coeur for all of us – including scientists, investors, and anyone who is aging – to take seriously the changes coming quickly with the rise of the Longevity Industry. Those of us working to develop new therapeutics to treat age-related disease don’t have the time or bandwidth to consider these larger issues. Thanks to longevity industry professionals Margaretta Colangelo and Dmitry Kaminskiy, we now have a broad – and brilliant – catalog of impacts heading our way as humanity develops new technologies and protocols to extend healthspan/lifespan. These impacts include paradigm shifts in healthcare – away from palliative care, toward health preservation and rejuvenation – as well as massive resource challenges posed by the coming Silver Tsunami. What’s most surprising about Longevity Industry 1.0 – aside from its visual richness – are the insights the authors provide on the seismic movements of capital that enhanced healthspan/lifespan will trigger, and the enormous opportunities this is already creating for investors.”

          

- Lou Hawthorne, CEO, NaNotics, LLC, Former EIR, Buck Institute for Research on Aging

“Longevity Industry 1.0 is a stupendous resource for understanding one of the most significant and underappreciated developments of the modern era.  The title—Defining the Biggest and Most Complex Industry in Human History—is not exaggerating.  Longevity, like the weather, has been an age-old subject for speculation.  But, Longevity is no longer a topic for idle chatter.  Now, longevity is happening in various ways and in many spheres. Multi-disciplinary science, machine learning, big data, social networking, Googlization of knowledge, Amazonizing of commerce, and an awakening political resolve are converging to put humankind on the precipice of achieving what has only been a pipe dream.   Dmitry Kaminskiy and Margaretta Colangelo have assembled a comprehensive reference that is both accessible and insightful.  They have made Longevity the shorthand term for the universe of scientific inquiry, massive engineering and translational efforts, and social and business transformation that are well underway. There is no better way to get up to speed on a subject of immense complexity and transcendent importance.”

          

- G. Alexander Fleming, M.D. Endocrinologist, Founder of the Metabesity Conference, and Executive Chairman, Kinexum, USA

““Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Margaretta Colangelo and Dmitry Kaminskiy is incredibly comprehensive. The intro alone has enough information that I could pore over it for days. We'll certainly reference this book since nobody out there is even coming close to capturing this industry as Margaretta and Dmitry have been doing in their articles and in their book.”

          

- Joe Pivarunas, Managing Editor, Nanalyze, Hong Kong

“Longevity, the final frontier…Aging is quickly becoming one of two – the other being climate change – critical factors for a possible mass extinction event. Longevity is not about the mere pursuit of immortality, but about achieving a new paradigm where Science, Politics, Finance and Technology intersect to build a new brave world. In their breaking ground new book, Margaretta Colangelo and Dmitry Kaminskiy distill the complexity of the Longevity Industry and remarkably demonstrate how aging issues and living longer can be addressed by easing the emotional and physical suffering and articulating a path toward a better and more inclusive world.”

          

- António Simões Pinheiro, Director, Banco Português de Gestão, Portugal

“In their new book “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History”, Dmitry Kaminskiy and Margaretta Colangelo provide an extensive look into the many areas that make up the Global Longevity Industry. If you’re interested in the current state of Longevity Science, Longevity Politics, and Longevity Financial Instruments including AgeTech, WealthTech, and FinTech, then this is the book for you.”

          

- Zoltan Istvan, American journalist, entrepreneur, and futurist, US

“When you work in frontier fields that go against the current status quo, and strive to push forward new paradigm shifts in established domains as complex as biomedicine and healthcare, the majority of people you meet are resistant to change, and you have to expend a lot of effort to show them why your way is the way of the future. This is why it was such a breath of fresh air when I first met Dmitry Kaminskiy, who completely got it. He had already read my book, The Patient as CEO, and given that he was already pushing forward the agenda of a paradigm shift from treatment to prevention, increasing emphasis on preventive medicine for national healthcare systems, and the practical implementation of Longevity technologies to increase Healthy Longevity not in ten years, but right now, I had to say very little to get my point across. And, given that he was an entrepreneur and venture capitalist advancing the agenda of health as new wealth, the idea of the patient as the CEO, and the individual as the manager of their own wellness, my thoughts were completely intuitive to him from the very start. When he and Margaretta Colangelo invited me to guest-author a section introducing the rapidly-advancing realm of Precision Medicine for “Longevity Industry 1.0: Defining the Most Complex Industry in Human History”, I was delighted to contribute, and I’m glad to do what I can to help such a novel and important book aiming to bring the major insights and near-future trajectory of the coming Longevity revolution to the public.”

          

- Robin Farmanfarmaian, author of The Patient as CEO: How Technology Empowers the Healthcare Consumer

“The new book “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Dmitry Kaminskiy and Margaretta Colangelo is a very welcome development in the Longevity Space! Commonly, the subject of longevity is considered as just and only a scientific subject, sometimes also referring to various “social implications”. This is probably the first time that the issue of longevity is considered truly holistically as an “industry” - including all the aspects of this industry’s underlying science, technology, investment ecosystem, financial instruments and policies. Of course, even this range of issues does not fully cover the longevity field, yet the authors did a great job creating a holistic, integrative vision of this extremely complex and multi-dimensional space. There is no doubt that this book will give an additional strong boost for the understanding and development of global longevity industry, and achieving its main intended dividend – the healthy longevity for all of us.”

          

- Ilia Stambler, PhD, Chief Science Officer, Vetek (Seniority) – the Movement for Longevity and Quality of Life, Israel

“15 years ago the longevity industry was non-existent, and today we see the entire books dedicated to it. Insilico Medicine powers most of the credible groups and startups in this emerging industry and I am very happy to see many of these partners abundantly covered in “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History”, an important book by Dmitry Kaminskiy and Margaretta Colangelo, authors deeply entrenched in the business of longevity”

          

- Alex Zhavoronkov, PhD, CEO, Insilico Medicine, Hong Kong

“The subject of Dmitry Kaminskiy and Margaretta Colangelo’s book, “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” is of interest globally. The complexity of aging is the Holy Grail. I’m working with the Principality of Monaco to understand why they have the best longevity in the world in their 2km2 patch. Like another wealthy city state with a different gene pool, Singapore, both have top-5 global life expectancy and infant mortality while spending only 3.5-4% of GDP for open access to public health systems. We are focused on environmental health and epigenetic differences in global longevity to see if any of that advantage can be globalized.”

          

- Douglas Miller, MD, CEO Cognitivediagnosis, Former Dean of Medicine, New York Medical College, USA

““Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Dmitry Kaminskiy and Margaretta Colangelo promises to be immensely useful—I greatly look forward to using it!”

          

- Christine Peterson, Co-founder and Senior Fellow, Foresight Institute

“The longevity industry is one of the most exciting and complex, filled with potential for innovation that can change the course of human health and thus of humanity. To take the right steps in the right direction, it’s important that we understand market forces, the challenges, and the opportunities. There’s no better book to ground us in the fundamentals and to set the foundation for the future than “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History”. Well done Margarretta and Dmitry for stepping up and providing the industry with what it needs: a framework off of which we can build.”

          

- Naheed Kurji, President & CEO at Cyclica and Executive Officer, Alliance for Artificial Intelligence in Healthcare, Canada

“I'm very much looking forward to reading the new book “Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History” by Dmitry Kaminskiy and Margaretta Colangelo especially the chapters where the authors describe the convergence of AI, advanced data science, biology of aging, and longevity research which will accelerate important medical discoveries that will benefit all of humanity.”

          

- Gopal Karemore, PhD, Principal Data Scientist, Novo Nordisk, Denmark

“I am delighted to see this latest of Dmitry Kaminsky’s many important contributions to the emerging, and exploding, longevity industry. He and his co-author Margaretta Colangelo have composed a volume that will serve as a great source for investors contemplating entering this space but intimidated by the required learning curve. I am sure it will also be hugely valuable to all those interested in monitoring and contributing to this foremost crusade in the history of mankind - the escape from our historical certainty that we will get sick when we get old.”

          

- Aubrey de Grey, biomedical gerontologist, Chief Science Officer of the SENS Research Foundation, VP of New Technology Discovery at AgeX Therapeutics, Editor-in-Chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging, and co-author of Ending Aging. (US)